SSA
ARKG icon

Schonfeld Strategic Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Schonfeld Strategic Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-7,787
Closed -$265K – 1760
2023
Q2 		$265K Buy
+7,787
New +$245K ﹤0.01% 1435

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

Schonfeld Strategic Advisors's ARKG Position: Q3 2023 in Review

Schonfeld Strategic Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2023, closing a stake of 7,787 shares — an estimated $265K sold.

Schonfeld Strategic Advisors first reported a position in ARKG in Q2 2023 and held it in 1 quarter. The position peaked at $265K in Q2 2023. 286 funds tracked by Wall St. Rank hold ARKG as of Q3 2023.

  • Schonfeld Strategic Advisors reported no remaining ARK Genomic Revolution ETF position as of Q3 2023 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 7,787 ARK Genomic Revolution ETF shares in Q3 2023, an estimated $265K.
  • Schonfeld Strategic Advisors first reported a position in ARK Genomic Revolution ETF in Q2 2023 and held it in 1 quarter.
  • Schonfeld Strategic Advisors's ARK Genomic Revolution ETF position peaked at $265K in Q2 2023.
  • 286 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.